Novel Trial for the Treatment of Steroid Dependency in Minimal Change Disease: Combined Therapy of Camostat Mesilate and Glycyrrhizin
暂无分享,去创建一个
[1] Y. Taguma,et al. Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics. , 1992, Nihon Jinzo Gakkai shi.
[2] Y. Taguma,et al. Effect of camostat mesilate on persistent proteinuria of IgA nephropathy. , 1992, Nephron.
[3] F. Shimada,et al. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. , 1991, Endocrinologia japonica.
[4] H. Makino,et al. Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy. , 1991, The Journal of diabetic complications.
[5] Y. Taguma,et al. Effect of camostat mesilate for the treatment of advanced diabetic nephropathy. , 1990, The Journal of laboratory and clinical medicine.
[6] Y. Taguma,et al. Effect of camostat mesilate on heavy proteinuria in various nephropathies. , 1989, Clinical nephrology.
[7] M. Mihatsch,et al. Risk factors for the development of chronic cyclosporine-nephrotoxicity. , 1988, Clinical nephrology.
[8] W. Kaufmann,et al. In vivo effects of camostat mesilate on plasma kallikrein, plasma kininase II and renal kallikrein of man. , 1987, Arzneimittel-Forschung.
[9] P. Hoyer,et al. CYCLOSPORIN IN FREQUENTLY RELAPSING MINIMAL CHANGE NEPHROTIC SYNDROME , 1986, The Lancet.
[10] R. Kikkawa,et al. Hypokalemia and sodium retention in patients with diabetes and chronic hepatitis receiving insulin and glycyrrhizin. , 1983, Endocrinologia japonica.
[11] L. Wash,et al. Licorice-induced pseudoaldosteronism. , 1975, American journal of hospital pharmacy.
[12] M. Muramatu,et al. Inhibitory effects of -amino acid esters on trypsin, plasmin, plasma kallikrein and thrombin. , 1971, Biochimica et biophysica acta.
[13] M. Muramatu,et al. Inhibitory effects of -guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin. , 1971, Biochimica et biophysica acta.